Minireviews
Copyright ©The Author(s) 2021.
World J Clin Cases. Sep 6, 2021; 9(25): 7319-7329
Published online Sep 6, 2021. doi: 10.12998/wjcc.v9.i25.7319
Table 1 Clinical features of Heyde’s syndrome
Due to
Symptoms
Signs
GI bleedHematemesis; Hematochezia; Melena; Abdominal painPallor; Blood on rectal exam; Orthostasis
Aortic stenosisDyspnea on exertion; Syncope; Fatigue; Exertional chest painLow volume slow rising; carotid pulse; Ejection systolic murmur; Absence of physiologic S2 split
Acquired vWSEasy bruisability; Mucosal bleeding; Heavy menstrual bleedingHemarthosis; Hematoma
Table 2 Aortic valve replacement in Heyde’s syndrome
Ref.
Year
Type of study
No of patients
Type of aortic valve replacement
Outcome (Positive)
Outcome (negative)
Love et al[13]1982Case series3SurgicalComplete resolution of GI bleed
Scheffer et al[15]1986Case report1Surgical-porcineNo GI bleeding during 9 mo follow up
Cappell et al[40]1986Case series2SurgicalNo further bleeding with negative stool guaiac in one pt at 18 mo followup; Disappearance of angiodysplasia by endoscopy with no further bleeding in 2 nd patient at 15 mo follow up
Abi-akar et al[41]2011Case report1Surgical- bio prostheticNo bleeding or blood transfusion at 9 mo follow up
Thompson et al[42]2012Retrospective review (1971-2001)57surgical bioprosthetic(47); mechanical(10)45 patients (79%) had no recurrence of GI bleeding in 15 year followup12 patients had persistent GI bleeding post AV replacement
Kadkhodayan et al[43]2012Case report1TAVRNo further episodes of GI bleeding post discharge
Balbo et al[44]2016Case report1TAVRNo GI bleeding at 3 and 6 mo of follow up post TAVR
Alshuwaykh et al[45]2018Case report 1TAVRNo further bleeding with stable Hemoglobin at 6 mo follow up Melena requiring blood transfusion at 2 wk follow up
Garcia et al[46]2019Case report1Surgical, mechanical No new episodes of GI bleeding post valve replacemet
Famularo et al[47]2020Case report1TAVRNo GI bleeding at 3 follow up post TAVR
Godino et al[48]2012-13Retrospective (2007-2012)7TAVRDuring a mean follow-up interval of 22 ± 15 mo, 6 patients (86%) had no recurrence of GI bleedingOne patient had TAVR failure with re hospitalization and blood trasnfusion